Literature DB >> 12051730

Ultrastructure of nuclear aggregates formed by expressing an expanded polyglutamine.

Noriko Hazeki1, Tadashi Tsukamoto, Ikuru Yazawa, Minami Koyama, Shunji Hattori, Iori Someki, Takeshi Iwatsubo, Koichiro Nakamura, Jun Goto, Ichiro Kanazawa.   

Abstract

Intranuclear inclusions have been observed in the brains of patients affected with Huntington's disease (HD). Neuro 2A cells that transiently expressed HD exon 1 bearing 74 glutamine repeats linked to the green fluorescent protein (GFP) and the nuclear localization sequence (NLS) contained aggregates in nuclei. The aggregates were purified by fractionation with centrifugation followed by fluorescence-activated cell sorting (FACS). Heat treatment of the aggregate in an SDS sample buffer caused the dense aggregate cores to disappear and generated a basket-like structure composed of fibrils. Biochemical analysis of the aggregates revealed that the HD exon 1-GFP fusion protein was the major component. The heterogeneous nuclear ribonucleoproteins F and H, histones and ubiquitin were found to be associated with the aggregates. Our observations suggest that the N-terminal fragment of huntingtin may organize the skeletal structure of the aggregates and may disturb normal cellular functions by trapping other proteins within the aggregates. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051730     DOI: 10.1016/S0006-291X(02)00498-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells.

Authors:  Hideyuki Mukai; Takayuki Isagawa; Emiko Goyama; Shuhei Tanaka; Neil F Bence; Atsuo Tamura; Yoshitaka Ono; Ron R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-22       Impact factor: 11.205

2.  Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties.

Authors:  Nathan Riguet; Anne-Laure Mahul-Mellier; Niran Maharjan; Johannes Burtscher; Marie Croisier; Graham Knott; Janna Hastings; Alice Patin; Veronika Reiterer; Hesso Farhan; Sergey Nasarov; Hilal A Lashuel
Journal:  Nat Commun       Date:  2021-11-12       Impact factor: 14.919

Review 3.  The ubiquitin-proteasome pathway in Huntington's disease.

Authors:  Steven Finkbeiner; Siddhartha Mitra
Journal:  ScientificWorldJournal       Date:  2008-04-20

Review 4.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

5.  Therapeutic Strategies in Huntington's Disease.

Authors:  Ichiro Kanazawa
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

Review 6.  A glass menagerie of low complexity sequences.

Authors:  Randal Halfmann
Journal:  Curr Opin Struct Biol       Date:  2016-05-31       Impact factor: 6.809

7.  Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity.

Authors:  Hui Zhou; Fengli Cao; Zhishan Wang; Zhao-Xue Yu; Huu-Phuc Nguyen; Joy Evans; Shi-Hua Li; Xiao-Jiang Li
Journal:  J Cell Biol       Date:  2003-10-13       Impact factor: 10.539

Review 8.  Pathology and function of nuclear amyloid. Protein homeostasis matters.

Authors:  Anna von Mikecz
Journal:  Nucleus       Date:  2014 Jul-Aug       Impact factor: 4.197

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.